| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 12.972 | 39.510 | 71.378 | 66.974 | 111.499 | 138.792 | 148.497 | 162.523 |
| Total Income - EUR | - | 0 | 12.972 | 39.510 | 71.378 | 66.974 | 111.506 | 138.792 | 148.497 | 162.523 |
| Total Expenses - EUR | - | 445 | 10.542 | 27.950 | 28.075 | 18.243 | 23.159 | 18.206 | 35.514 | 37.954 |
| Gross Profit/Loss - EUR | - | -445 | 2.430 | 11.561 | 43.303 | 48.731 | 88.347 | 120.587 | 112.983 | 124.569 |
| Net Profit/Loss - EUR | - | -445 | 2.040 | 10.375 | 41.162 | 46.842 | 85.069 | 117.997 | 111.607 | 119.693 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Abbasurg S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 508 | 3.009 | 2.407 | 1.821 | 12.053 | 9.889 | 8.879 |
| Current Assets | - | 45 | 1.826 | 10.463 | 38.864 | 45.535 | 85.091 | 107.690 | 103.297 | 183.910 |
| Inventories | - | 0 | 637 | 818 | 0 | 0 | 172 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 10.297 | 10.726 | 26.546 | 97.533 | 83.190 | 124.537 |
| Cash | - | 45 | 1.188 | 9.645 | 28.567 | 34.809 | 58.373 | 10.157 | 20.107 | 59.373 |
| Shareholders Funds | - | -401 | 1.646 | 10.427 | 41.212 | 46.892 | 85.128 | 118.364 | 111.655 | 119.805 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 445 | 179 | 545 | 661 | 1.051 | 1.784 | 1.379 | 1.530 | 72.984 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Abbasurg S.r.l.